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Abstract
Background:  The rapid increase in the development of mouse models is resulting in a growing
demand for non-invasive physiological monitoring of large quantities of mice. Accordingly, we
developed a new system for recording electrocardiograms (ECGs) in conscious mice without
anesthesia or implants, and created Internet-accessible software for analyzing murine ECG signals.
The system includes paw-sized conductive electrodes embedded in a platform configured to record
ECGs when 3 single electrodes contact 3 paws.
Results:  With this technique we demonstrated significantly reduced heart rate variability in
neonates compared to adult mice. We also demonstrated that female mice exhibit significant ECG
differences in comparison to age-matched males, both at baseline and in response to β -adrenergic
stimulation.
Conclusions:  The technology we developed enables non-invasive screening of large numbers of
mice for ECG changes resulting from genetic, pharmacological, or pathophysiological alterations.
Data we obtained non-invasively are not only consistent with what have been reported using
invasive and expensive methods, but also demonstrate new findings regarding gender-dependent
and age-dependent variations in ECGs in mice.
Background
Although electrocardiograms (ECGs) have been ob-
tained in conscious mice, currently reported techniques
require restraint [1] or anesthesia and surgical implanta-
tion of telemetry devices [2,3,4]. Anesthesia, however,
may depress cardiovascular function, and adequate re-
covery after transmitter implantation in mice is nearly 3
weeks [3,5]. Accordingly, we developed a non-invasive
technique for obtaining ECGs in conscious mice by plac-
ing the animal on a platform embedded with paw-sized
ECG electrodes connected to an amplifier. This method
is much less traumatic, requires no anesthesia or sur-
gery, and promotes rapid screening of large quantities of
mice. ECG data we obtained non-invasively in conscious
mice are comparable to those recently published using
surgically implanted telemetry devices [2,4]. To test the
efficacy of our system, we evaluated ECGs in mice of ei-
ther sex, of several strains, and of different ages. Moreo-
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ver, we tested whether our system could detect ECG
alterations in response to pharmacological challenge by
isoproterenol. The baseline heart rate data and respons-
es to the β -adrenergic agonist isoproterenol we recorded
non-invasively in mice are comparable to data published
using invasive methods[6]. We developed an ECG signal
processing, analyzing, and database Web portal, which
we named e-MOUSE™, accessible to the biotechnology
community. The advantages of the ECG recording and
analyses paradigm we developed are clear, given the high
cost of breeding, housing, and transporting mice, and the
call for comprehensive yet widely available phenotyping
tests [7].
Results
We recorded ECGs in 10 males and 10 females each of
C57BL/6, 129/Sv, and FVB/N mice, three inbred strains
commonly used to model human diseases. A representa-
tive ECG recording from an adult male C57BL/6 mouse
is shown in Fig. 1. Since the mice are conscious, baseline
artifact and noise are apparent in the unfiltered signals.
Yet, the P-waves and T-waves are discernible by eye and
interpretable by the software algorithmic processing of
the signal digitized at 2500 samples per second. Analyses
of the digitized signals via e-MOUSE™ demonstrated
significantly faster heart rates in C57BL/6 female mice
than in males (741 ± 2 bpm vs. 692 ± 5 bpm, P < 0.05, n
= 10) and shorter QRS duration (7.5 ± 0.2 ms vs. 8.1 ± 0.2
ms, P < 0.05). Table 1 summarizes results in 129/Sv mice
(10 males and 10 females), again demonstrating faster
heart rate and shorter QRS duration and QT interval in
female mice than in age-matched males. Rate corrected
QT (QTc) in male 129/Sv mice was significantly longer
than in females (66.7 ± 1.9 ms vs. 58.4 ± 1.6 ms, P < 0.05).
Gender differences in heart rate were also apparent in
the FVB/N strain [736 ± 5 bpm in males (n = 10) vs. 706
± 7 bpm in females (n = 10), P < 0.05].
Reducing the spacing of the electrodes allowed us to
record ECGs in 6-day and again in 12-day old nursling
C57BL/6 mice (8 males and 5 females) and return them
to their mother. The ECG from a 6-day-old C57BL/6
nursling female is shown in Fig. 2. Heart rate variability
in neonates was significantly less than in adults (2.5 ± 0.4
bpm vs. 21 ± 2 bpm, P < 0.05). Heart rate in nursling fe-
males was significantly slower than in adult females (655
± 6 bpm vs. 741 ± 2 bpm, P < 0.05). Interestingly, the
gender differences in heart rate we observed in adult
mice were absent in 6-day old and 12-day old neonates.
Upon weaning (21 days old), however, gender differences
in heart rate became apparent [697 ± 14 bpm in males (n
= 5) vs. 750 ± 8 bpm in females (n = 3), P < 0.05].
The acute increase in heart rate within the first minutes
following one intraperitoneal injection of the β -adrener-
Figure 1
Electrocardiogram from a conscious adult male C57BL/6










Table 1: Electrocardiographic parameters in male and female 129/Sv, C57BL/6, and FVB conscious mice.
129/Sv C57BL/6 FVB
Males Females Males Females Males Females
(n = 10) (n = 10) (n = 10) (n = 10) (n = 10) (n = 10)
Heart Rate 
(bpm)
571 ± 13 689 ± 12 * 692 ± 5 741 ± 2 * 736 ± 57 0 6  ± 7 *
HR var (bpm) 15 ± 4 20 ± 41 2  ± 31 5  ± 3 33 ± 21 6  ± 2 *
PR (ms) 31.9 ± 1.3 28.3 ± 0.6* 26.0 ± 0.8 24.4 ± 0.7 25.4 ± 0.6 27.7 ± 0.6 *
QRS (ms) 9.6 ± 0.3 8.5 ± 0.1* 8.1 ± 0.2 7.5 ± 0.2* 7.4 ± 0.1 7.7 ± 0.1
QT (ms) 70.2 ± 1.8 54.7 ± 2.0* 55.4 ± 0.8 53.8 ± 0.6 53.9 ± 1.2 55.7 ± 1.4
QTc (ms) 66.7 ± 1.9 58.4 ± 1.6* 59.0 ± 0.8 58.7 ± 0.3 59.3 ± 1.2 59.9 ± 1.6
Values are mean ± SE. *, P < 0.05 vs. males within strain. HR var, heart rate variability.BMC Physiology (2001) 1:6 http://www.biomedcentral.com/1472-6793/1/6
gic agonist isoproterenol (2.5 µg/g) was significantly less
in female compared to male C57BL/6 adult mice (+5 ±
2% females vs. +12 ± 2% males, P < 0.05, n = 5 for each
group). Saline injection had no effect on heart rate. After
3 days of repeated isoproterenol injection (2.5 µg/g, once
at 9AM and once at 9PM), heart rate in males prior to the
6th injection was significantly reduced compared to con-
trol heart rate in males prior to the 1st injection, whereas
the heart rate in females did not change. Both male and
female mice exhibited significant acute increases in heart
rate (+27 ± 6% males and +22 ± 3% females) after the 6th
injection of the drug on day 3 (P < 0.05 compared to %
increases following 1st injection on day 1). Fig. 3 illus-
trates significant electrocardiographic alterations imme-
diately after the 1st administration of isoproterenol on
day 1 in a C57BL/6 male mouse. ST segment depression,
suggestive of acute subendocardial ischemia, was con-
sistently observed in C57BL/6 male mice but not in all fe-
male mice immediately following administration of
isoproterenol. Heart weight in males and females treated
with isoproterenol for 3 days was significantly increased
(16%) compared to hearts from mice treated with saline
for 3 days (P < 0.05).
Discussion
This report describes the development of a system for
non-invasively recording ECGs in conscious mice; nei-
ther attachment of wires, nor anesthesia, nor surgical
implantation of devices is required. Our heart rate data
in conscious mice are comparable to those obtained us-
ing sutured steel wire [8] and chronic indwelling cathe-
ters [6]. Our ECG measurements are comparable to
those obtained using implantable telemetry devices
[2,4]. This non-invasive method, standardized protocol,
and Internet-accessible mouse ECG analyses software
(e-MOUSE™) may reduce the heterogeneity in data col-
lected from different laboratories [7].
Strain & Gender Differences in ECGs in Adult Mice
To our knowledge, this is the first study to describe gen-
der differences in heart rate in genetically homogenous
strains of conscious mice. Studies in humans [9,10] and
in rats [11,12] have shown females to have faster heart
rates than males, differences that disappear with age
[10,13]. In C57BL/6 mice and in 129/Sv mice, we found
that conscious females exhibited significantly faster
heart rates than male mice. In FVB/N mice, however, we
noted faster heart rates and briefer ECG time intervals in
male compared to female mice. Mitchell et al., using im-
planted transmitters, reported slightly but insignificant-
ly faster heart rates in male compared to female FVB
mice [4]. Gender and strain differences in heart rate may
reflect differences in hormone activity, which are known
to affect cardiovascular autonomic regulation differen-
tially in males and females [9] and vary among mouse
strains [14]. Our strain-dependent observations agree
with results of invasive studies [8,6] and support the im-
portance of genetic factors in influencing heart rate.
Developmental Changes in ECGs in Conscious Neonatal 
Mice
We found that the gender differences apparent in
C57BL/6 adults were absent in nursling mice. Reduced
activity in newborns could contribute to reduced heart
rate and heart rate variability. However, observations in
quietly resting adult mice (n = 3), monitored 30 min af-
ter placement on the recording platform, of reduced
heart rate (471 ± 20 bpm) and increased heart rate varia-
bility (53 ± 6 bpm) suggest that the results in neonates
may be attributable to reduced sympathetic and para-
sympathetic signaling [15]. The time-domain heart rate
variability data we obtained non-invasively are compara-
ble to those obtained using implanted telemetry devices
[2,16]. The developmental changes in heart rate we
measured in mice parallel those in human neonates
[13,17], lambs [18], and newborn rats [19]. Moreover, our
observations in neonatal mice are in agreement with
Wang et al. who reported progressive and significant
shortening of R-R intervals during neonatal develop-
ment [1]. Accordingly, our approach, adaptable to the
study of small mice that might otherwise die from an-
esthesia or surgery, might be valuable in examining de-
velopmental changes and abnormalities [13,17].
Effects of Sympathetic Stimulation in Conscious Mice
The blunted heart rate increase in response to β -adren-
ergic stimulation in conscious C57BL/6 female mice is
consistent with gender related differences in baroreflex
control of heart rate in healthy humans [20]. Estrogen
Figure 2
Electrocardiogram from a conscious neonate (6 days old)
female C57BL/6 mouse. Heart rate variability in neonates
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has been shown to enhance baroreflex sensitivity [21]
and attenuate the response of heart rate to administra-
tion of isoproterenol in rats [22]. After repeated injec-
tions of isoproterenol, heart rate decreased and the QRS
duration increased significantly in male mice, but did not
change in female mice. Yet, both males and females dem-
onstrated increased sensitivity to acute isoproterenol in-
jection after repeated administration that resulted in
significant cardiac hypertrophy [23,24]. We observed a
16% increase in heart mass in both sexes after 3-days of
isoproterenol treatment compared to mice treated with
equivolume of saline. Although β -adrenoceptor desensi-
tization [23] or reduced ATPase activity [25] may ac-
count for the decrease in basal heart rate in the
hypertrophied male hearts, the increased sensitivity to
isoproterenol may support the hypotheses of ischemia-
induced activation of β -adrenoceptor kinase [26] or
modulation of G-protein signaling to preserve adenylate
cyclase activity [27]. To our knowledge, this is the first
report that describes electrocardiographic evidence of
myocardial ischemia in conscious mice, although ST seg-
ment changes have characterized isoproterenol-induced
ischemia in rat [28] and man [29]. Why males consist-
ently developed ST segment depression following isopro-
terenol administration and females did not remains
unanswered. However, significant gender-related differ-
ences in the expression of glutathione S-transferases
(GST) have been observed in mice, with female mice ex-
pressing significantly more of this antioxidant than male
mice [30]. In mice, isoproterenol-induced oxidative
stress may be attenuated in females due to higher levels
of GST [31].
Study Limitations
Mice are sensitive to even modest handling [3,8] and
transport [3,32]. The ECG indices we measured may re-
flect physiologic responses to the experimental environ-
ment relative to its home cage. We encourage a 10 min
acclimation period prior to recording data to attenuate
effects consequent to handling and transport. Usually
mice establish contact between 3 electrodes and 3 limbs
within 5 minutes after acclimation to record a continu-
ous ECG for approximately 2 seconds. The duration of
the ECG recording should be considered in the interpre-
tation of heart rate variability [33]. The age, gender and
strain variations in heart rate may reflect age, gender and
strain variations in physiologic responses to transport
[32], handling [3], and adaptation to repeated measure-
ments [8]. Yet, the inter-strain differences in heart rate
we non-invasively obtained after ECG recordings of
short duration are in agreement with invasive experi-
mental techniques intended to monitor heart rate in
mice as caged [6,8]. Our measurements were made in
daytime hours, disrupting the less active phases of the
mouse circadian cycle. Future innovation might incorpo-
rate an array of conductive electrodes into the animals'
cages to eliminate the effects of handling and transport,
and perhaps enable timed recordings.
Materials and Methods
Mice
Young adult mice (9 ± 1 weeks old; 21 ± 1 g) from 3 com-
monly used inbred strains, C57BL/6, 129/Sv, and FVB/
N (The Jackson Laboratory, Bar Harbor, ME), were
housed in standard conditions within the Animal Re-
source Facility at the Beth Israel Deaconess Medical
Center, Boston MA. Nursling C57BL/6 mice of either sex
were examined at post-natal day 6 and 12 and returned
to their mothers. The same mice, weaned, were exam-
ined at 3 weeks of age.
ECG recording
Mice were gently removed from their cages and posi-
tioned on the ECG recording platform. An array of gel-
coated ECG electrodes (Red Dot; 3 M, St. Paul, MN) were
embedded in the floor of the platform and spaced to pro-
vide contact between the electrodes and animals' paws.
For adults, the spacing between electrodes was 3 cm, and
for nurslings, the spacing was reduced to 2.5 cm. Filter
paper, with openings for the electrodes, prevented
mouse urine from short-circuiting the signals. The elec-
trodes were connected to an amplifier (HP78901A,
Hewlett-Packard, Andover, MA) by a shielded 3-elec-
trode lead set (M1605A Snap, Hewlett-Packard, Ando-
ver, MA). Since even modest handling of mice may
induce alterations in heart rate [6], each mouse was per-
mitted to acclimatize for 10 min prior to collection of
baseline data. The signals were digitized with 16-bit pre-
Figure 3
Electrocardiogram from the C57BL/6 male mouse of Fig. 1
recorded immediately after an intraperitoneal injection of 2.5
µg/g isoproterenol on day 1, showing ST segment depression
suggestive of acute subendocardial ischemia.
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cision (DI-220, DATAQ Instruments, Inc., Akron, OH) at
a sampling rate of 2500 samples/second. When mice
were sitting or otherwise positioned such that the paws
were not in contact with three electrodes, the output
from the amplifier was discarded. Only data from contin-
uous recordings of 20-30 ECG signals were used in the
analyses. Data were transmitted to the mousespecif-
ics.com Internet site (Mouse Specifics, Inc., Boston, MA)
using standard file-transfer protocols for ECG signal
analyses by e-MOUSE™.
ECG analyses
Each signal was analyzed using e-MOUSE™, an Inter-
net-based physiologic waveform analysis portal. e-
MOUSE™ incorporates Fourier analyses and linear
time-invariant digital filtering of frequencies below 2 Hz
and above 100 Hz to minimize environmental signal dis-
turbances. The software uses a peak detection algorithm
to find the peak of the R-waves and to calculate heart
rate. Heart rate variability was calculated as the mean of
the differences between sequential heart rates for the
complete set of ECG signals. Subsequently, determina-
tion of 1st and 2nd derivatives and algebraic "if-thens"
search the ECG signals for probable P-wave peaks and
onset and termination of QRS complexes. Since the T-
wave is not separate from the QRS in rodent ECGs [28,
34], there have been discrepancies in the definition of the
QT interval and reported values [4]. In accord with
Mitchell et al. [4], we routinely included the inverted
and/or biphasic portions of the T-wave in our calcula-
tions of the QT interval. We defined the end of the T-
wave of each signal as the point where the signal re-
turned to the isoelectric line [1,35] [the mean voltage be-
tween the preceding P-wave and QRS interval]. The QT
intervals were rate corrected (QTc) by application of the
equation recommended by Mitchell et al. [4] for use in
mice. The software plots its interpretation of P,Q,R,S,
and T for each beat so that spurious data resulting from
unfiltered noise or motion artifacts may be rejected. e-
MOUSE™ then calculates the mean of the ECG time in-
tervals for each set of waveforms.
β -adrenoceptor stimulation
To test the sensitivity of our system for describing ECG
alterations in response to a drug, C57BL/6 mice were
given either an intraperitoneal injection of 2.5 µg/g (-)-
isoproterenol (Sigma, St. Louis, MO) (5 males, 5 fe-
males) dissolved in 0.1 ml saline or an equal volume of
saline (5 males, 5 females), twice daily for 3-days. ECGs
were recorded within 5 min prior to each injection and
between 1 and 2 min after each injection to capture the
peak of the response to the drug [6]. After the last meas-
urement, mice were euthanized by intraperitoneal ad-
ministration of pentobarbital (150 mg/Kg), consistent
with the American Veterinary Medical Association Panel
on Euthanasia guidelines. Excised hearts, excluding atria
and blotted dry, were then weighed.
Statistics
Data are presented as the means ± SE. Comparisons be-
tween genders among strains were performed using Stu-
dent's  t-test for unpaired observations. Effects of
isoproterenol or saline injections within groups were
performed using Student's t-test for paired observations,
and between group comparisons using Student's t-test
for unpaired observations. Differences were considered
significant with P < 0.05.
Conclusions
We developed a non-invasive technique for obtaining
ECGs in conscious mice. We developed an Internet-ac-
cessible portal for analyses of mouse electrocardiograms.
Using this system, we demonstrated significant strain,
gender and age-dependent differences in electrocardio-
grams in mice. Moreover, we demonstrated significant
gender-dependent differences in the cardiovascular re-
sponse to β -adrenoceptor stimulation. Our results may
suggest that the stimulatory effects of genes and drugs on
cardiac function may be more profound in male or
masked in female mice. This non-invasive and rapid ECG
phenotyping technique may improve the quality and in-
crease the quantity of data collected from mouse models.
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